Participants were randomized to placebo or retatrutide at 1 mg, 4 mg (dose-escalation), 4 mg (no escalation), 8 mg (escalation), 8 mg (no escalation), or 12 mg (escalation) for 48 weeks, following a slow titration protocol
GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion
Administration & Protocol In clinical trials, Retatrutide is administered via subcutaneous injection, typically once per week
Both enrolled adults with obesity or overweight without type 2 diabetes, which makes the comparison more reasonable than most cross-trial matchups
Pharmaceutical versions amplify these effects, reducing appetite and promoting satiety, or a feeling of fullness
When you're in the phase of researching your health insurance options, (whether because it's open enrollment period, or you've experienced a qualifying life event), there are a couple of options for finding out how different health insurance plans handle GLP-1 coverage: Check the drug formulary: When reviewing and comparing your plan options on healthcare.gov or through a platform like StretchDollar, look for the drug formulary to view the list of drugs the provider covers, and which tier different types of drugs fall into